PERMITIL Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Permitil, and when can generic versions of Permitil launch?
Permitil is a drug marketed by Schering and is included in three NDAs.
The generic ingredient in PERMITIL is fluphenazine hydrochloride. There are nineteen drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the fluphenazine hydrochloride profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Permitil
A generic version of PERMITIL was approved as fluphenazine hydrochloride by FRESENIUS KABI USA on April 16th, 1987.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for PERMITIL?
- What are the global sales for PERMITIL?
- What is Average Wholesale Price for PERMITIL?
Summary for PERMITIL
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 3 |
Raw Ingredient (Bulk) Api Vendors: | 128 |
Clinical Trials: | 1 |
Patent Applications: | 1,599 |
DailyMed Link: | PERMITIL at DailyMed |
Recent Clinical Trials for PERMITIL
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Canadian Institutes of Health Research (CIHR) | Phase 2 |
Centre for Addiction and Mental Health | Phase 2 |
US Patents and Regulatory Information for PERMITIL
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Schering | PERMITIL | fluphenazine hydrochloride | CONCENTRATE;ORAL | 016008-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Schering | PERMITIL | fluphenazine hydrochloride | TABLET;ORAL | 012034-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
Schering | PERMITIL | fluphenazine hydrochloride | TABLET, EXTENDED RELEASE;ORAL | 012419-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |